Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v2.4.0.6
Stock-Based Compensation
9 Months Ended
Sep. 30, 2012
Stock-Based Compensation [Abstract]  
Stock-Based Compensation

12.             Stock-Based Compensation

On August 5, 2003, the Company established a stock option plan (the “Plan”).  Under the Plan, the Company grants stock options to key employees, directors and consultants of the Company.  For all grants prior to September 12, 2005 and grants to employees of the Company after September 12, 2005, the vesting period is 30% on the first anniversary of the grant date, an additional 30% on the second anniversary and the remaining 40% on the third anniversary.  Options expire between five and ten years from the date of grant.

For grants to non-employee consultants of the Company after September 12, 2005, the vesting period is between one to three years, subject to the fulfillment of certain conditions in the individual stock option grant agreements, or 100% upon the occurrence of certain events specified in the individual stock option grant agreements.  Options authorized for issuance under the Plan total 17,000,000 after giving effect to an amendment to the Plan approved at the Annual Meeting of the Stockholders of the Company on June 2, 2006.  At September 30, 2012, 8,578,000 shares of common stock were available for issuance.

Prior to adoption of the Plan, the Company made restricted stock grants.  During 2003 all existing restricted stock grants were converted to stock options.  The converted options maintained the same full vesting period as the original restricted stock grants.

Accounting for Employee Awards

The Company’s results of operations for the three months ended September 30, 2012 and 2011 include share-based employee compensation expense totaling $44,905 and $161,876 respectively.  The Company’s results of operations for the nine months ended September 30, 2012 and 2011 include share-based compensation expense totaling $160,037 and $466,738 respectively.  Such amounts have been included in the statement of operations in general and administrative and research and development expenses.  No income tax benefit has been recognized in the statement of operations for share-based compensation arrangements as the Company has provided for a 100% valuation allowance on its deferred tax assets.

Employee stock option compensation expense is the estimated fair value of options granted amortized on a straight-line basis over the requisite vesting service period for the entire portion of the award.

Accounting for Non-Employee Awards

Stock compensation expenses related to non-employee options were $15,706 and $(20,787) for the three months ended September 30, 2012 and 2011, respectively.  Stock compensation expenses related to non-employee options were $42,500 and $46,517, for the nine months ended September 30, 2012 and 2011, respectively.  Such amounts have been included in the statement of operations in general and administrative and research and development expenses.

 

 

12.  Stock-Based Compensation (contd)

Summary of Stock Compensation Expense Recognized

Total stock-based compensation recognized by the Company in the three and nine months ended September 30, 2012 and 2011, and the period from inception (March 19, 2001) to September 30, 2012 is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative from

 

Three Months Ended September 30,

Nine Months Ended September 30,

March 19, 2001 (Inception) to

 

2012

2011

2012

2011

September 30, 2012

Statement of operations line item:

 

 

 

 

 

 

 

 

 

 

General and administrative:

 

 

 

 

 

 

 

 

 

 

Payroll

$

25,932 

$

138,170 

$

100,097 

$

397,192 

 

2,595,497 

Consulting and other professional fees

 

10,470 

 

(16,915)

 

32,965 

 

30,265 

 

819,488 

Research and development:

 

 

 

 

 

 

 

 

 

 

Payroll

 

18,973 

 

23,706 

 

59,940 

 

69,546 

 

1,031,989 

Consulting and other professional fees

 

5,236 

 

(3,872)

 

9,535 

 

16,252 

 

1,333,192 

 

 

 

 

 

 

 

 

 

 

 

Total

$

60,611 

$

141,089 

$

202,537 

$

513,255 

 

5,780,166 

 

Summary of Stock Option Transactions

There were 170,000 stock options granted at an exercise price of $0.38 with a fair value of $47,589 and 75,000 stock options granted at an exercise price of $0.48 with a fair value of $26,835 during the six months ended June 30, 2012.  There were 130,000 stock options granted at an exercise price of $1.84 and a fair value of $180,326,  100,000 stock options granted at an exercise price of $1.25 and a fair value of $91,334,  20,000 stock options granted at an exercise price of $1.22 and a fair value of $17,915, and 150,000 stock options granted at an exercise price of $1.12 and a fair value of $121,595 during the nine months ended September 30, 2011.

The fair value of options at the date of grant was estimated using the Black-Scholes option pricing model.  The Company took into consideration guidance under Accounting Standards Codification (“ASC”) 718, “Compensation-Stock Compensation” and Staff Accounting Bulletin (“SAB”) 107 when reviewing and updating assumptions.  The expected volatility is based upon historical volatility of the Company’s stock.  The expected term is based upon the simplified method as allowed under SAB 107.

 

The assumptions made in calculating the fair values of options are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30,

 

2012

2011

Black-Scholes weighted average assumptions

 

 

 

 

Expected dividend yield

%

%

Expected volatility

99-101

%

96-101

%

Risk free interest rate

0.62-0.89

%

0.11-2.29

%

Expected term (in years)

5 years

 

5 years

 

12.    Stock-Based Compensation (contd)

The following table summarizes the employee and non-employee share-based transactions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2012

2011

 

Number of Options

Weighted Average Exercise Price

Number of Options

Weighted Average Exercise  Price

Outstanding at

 

 

 

 

 

 

January 1

7,646,795 

$

1.05 
8,076,795 

$

1.01 

Granted

245,000 

 

0.41 
400,000 

 

1.39 

Exercised

-

 

-

(103,000)

 

0.39 

Cancelled

(150,000)

 

1.15 
(192,000)

 

1.21 

 

 

 

 

 

 

 

Outstanding at September 30

7,741,795 

$

1.03 
8,181,795 

$

1.03 

 

The following table summarizes information about stock options outstanding as of September 30, 2012 and December 31, 2011.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of Options

Weighted Average Exercise Price

Weighted Average Remaining Contractual Term

Aggregate Intrinsic Value

Outstanding at

 

 

 

 

 

 

September 30, 2012

7,741,795

$

1.03 

4.2 years

$

191,915.00 

 

 

 

 

 

 

 

Exercisable at

 

 

 

 

 

 

September 30, 2012

7,176,795 

$

1.03 

3.8 years

$

167,565.00 

 

 

 

 

 

 

 

Outstanding at

 

 

 

 

 

 

December 31, 2011

7,646,795 

$

1.05 

4.8 years

$

83,611.00 

 

 

 

 

 

 

 

Exercisable at

 

 

 

 

 

 

December 31, 2011

6,911,795 

$

1.02 

4.4 years

$

83,611.00 

 

The total intrinsic value of the options exercised was $9,200 and $103,450 for the three and nine months ended September 30, 2011, respectively.  There were no options exercised in the three and nine months ended September 30, 2012.  The weighted average fair value of the options vested was $0.92 and $0.85 for the nine months ended September 30, 2012 and 2011, respectively.

A summary of the Company’s unvested shares as of September 30, 2012 and changes during the nine months ended September 30, 2012 is presented below:

 

 

 

 

 

 

 

 

 

 

2012

 

Number of  Options

Weighted Average Fair Value at Grant Date

Unvested at January 1, 2012

735,000 

$

0.92 

Granted

245,000 

$

0.30 

Vested

(304,000)

$

0.92 

Cancelled

(111,000)

$

0.89 

 

 

 

 

Unvested at September 30, 2012

565,000 

$

0.66 

12.    Stock-Based Compensation (contd)

As of September 30, 2012 and December 31, 2011, there was $218,522 and $397,593 of total unrecognized compensation cost, respectively, related to all unvested stock options, which is expected to be recognized over a weighted average vesting period of 1.3 years and 1.6 years, respectively.